Package 10135-741-05

{"route": ["ORAL"], "spl_id": "3f7bca13-71ae-c3ed-e063-6294a90ac734", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "UR59KN573L"], "rxcui": ["854908", "854916", "854919"], "spl_set_id": ["df881501-42ae-624a-e053-2995a90ab2a0"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Marlex Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (10135-741-01)", "package_ndc": "10135-741-01", "marketing_start_date": "20220501"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (10135-741-05)", "package_ndc": "10135-741-05", "marketing_start_date": "20220501"}], "brand_name": "Bisoprolol Fumarate and Hydrochlorothiazide", "product_id": "10135-741_3f7bca13-71ae-c3ed-e063-6294a90ac734", "dosage_form": "TABLET", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "10135-741", "generic_name": "Bisoprolol Fumarate and Hydrochlorothiazide", "labeler_name": "Marlex Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bisoprolol Fumarate and Hydrochlorothiazide", "active_ingredients": [{"name": "BISOPROLOL FUMARATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "6.25 mg/1"}], "application_number": "ANDA215562", "marketing_category": "ANDA", "marketing_start_date": "20220501", "listing_expiration_date": "20261231"}